Premier Health of America Inc.

As of December 31, 2025, Premier Health of America Inc. has 55.51M shares outstanding.

These figures are as of December 31, 2025. The price-to-sales ratio is 0.02, and the price-to-book ratio stands at -0.10.

As of December 31, 2025, Premier Health of America Inc. trades at an EV/EBITDA multiple of 92.46 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.52 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Premier Health of America Inc. trades at an EV/FCF ratio of 2.29, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of December 31, 2025, Premier Health of America Inc. maintains a current ratio of 0.34, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -321.81, indicating conservative leverage, while an interest coverage ratio of -0.25 demonstrates limited ability to service its debt obligations.

Over the twelve months ended December 31, 2025, Premier Health of America Inc. posted a negative return on equity (ROE) of -191.46, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -27.78, reflecting losses generated across the asset base.

Over the twelve months ended December 31, 2025, Premier Health of America Inc. posted a gross margin of 16.19, reflecting its pricing power and cost economics. The operating margin of -10.55 and net profit margin of -17.94 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2025. Free cash flow yield stands at 1,096.59, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 843.32, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Premier Health of America Inc. shareholders.

As of December 31, 2025, Premier Health of America Inc. has an Altman Z-Score of -1.29, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.